Qube Research & Technologies Ltd - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 94 filers reported holding VBI VACCINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of VBI VACCINES INC
ValueSharesWeighting
Q4 2022$5,827
-73.5%
14,899
-52.0%
0.00%
Q3 2022$22,000
-94.3%
31,070
-93.5%
0.00%
-100.0%
Q2 2022$388,000
+162.2%
479,879
+439.8%
0.00%
+200.0%
Q1 2022$148,000
-10.3%
88,895
+26.3%
0.00%0.0%
Q4 2021$165,000
+79.3%
70,395
+139.2%
0.00%0.0%
Q3 2021$92,000
-63.6%
29,432
-61.0%
0.00%
-66.7%
Q2 2021$253,000
-21.2%
75,561
-32.8%
0.00%
-40.0%
Q3 2020$321,000112,3610.01%
Other shareholders
VBI VACCINES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$170,631,0002.76%
GENERAL AMERICAN INVESTORS CO INC 1,156,672$3,586,0000.46%
FIRST MIDWEST BANK TRUST DIVISION 503,058$1,559,0000.25%
Weil Company, Inc. 75,942$235,0000.20%
Frontier Wealth Management LLC 600,000$1,860,0000.17%
A.R.T. Advisors, LLC 28,971$90,0000.14%
Old Well Partners, LLC 43,810$136,0000.11%
Platform Technology Partners 30,100$93,0000.06%
Cambridge Investment Research Advisors, Inc. 1,714,744$5,316,0000.04%
TCI Wealth Advisors, Inc. 30,000$93,0000.04%
View complete list of VBI VACCINES INC shareholders